Cargando…
Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission
Although many cancer patients use complementary and alternative medicine, including Agaricus blazei Murill (ABM), safety is not yet well understood. Cancer survivors took 1.8, 3.6, or 5.4 g ABM granulated powder (Kyowa Wellness Co., Ltd., Tokyo, Japan) per day orally for 6 months. Adverse events wer...
Autores principales: | Ohno, Satoshi, Sumiyoshi, Yoshiteru, Hashine, Katsuyoshi, Shirato, Akitomi, Kyo, Satoru, Inoue, Masaki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092499/ https://www.ncbi.nlm.nih.gov/pubmed/21584278 http://dx.doi.org/10.1155/2011/192381 |
Ejemplares similares
-
Assessment of antioxidant and antidiabetic properties of Agaricus blazei Murill extracts
por: Wei, Qi, et al.
Publicado: (2019) -
An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy
por: Ellertsen, Linda K, et al.
Publicado: (2009) -
Effect of Agaricus blazei Murill on the Pulmonary Tissue of Animals with Streptozotocin-Induced Diabetes
por: Di Naso, Fábio Cangeri, et al.
Publicado: (2010) -
Characteristics of fucose-containing polysaccharides from submerged fermentation of Agaricus blazei Murill
por: Wang, Hsueh-Ting, et al.
Publicado: (2017) -
Critical review on chemical compositions and health-promoting effects of mushroom Agaricus blazei Murill
por: Huang, Kaiyuan, et al.
Publicado: (2022)